The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Topotecan (T) + Pazopanib (P) in platinum-resistant or intermediate-sensitive ovarian cancer: a phase I/II single-arm multicentre trial of the North-Eastern German Society of Gynaecologic Oncology: TOPAZ.
 
Radoslav Chekerov
Honoraria - AstraZeneca; Medac; Roche Pharma AG
Research Funding - Medac (Inst)
Travel, Accommodations, Expenses - Medac; Tesaro
 
Ulrich Canzler
No Relationships to Disclose
 
Hans-Georg Strauss
No Relationships to Disclose
 
Volkmar Müller
No Relationships to Disclose
 
Nikolaus de Gregorio
Travel, Accommodations, Expenses - Tesaro
 
Ulrich Hacker
No Relationships to Disclose
 
Tanja Neunhoeffer
No Relationships to Disclose
 
Rolf Richter
No Relationships to Disclose
 
Elena Ioana Braicu
Travel, Accommodations, Expenses - Fujirebio Diagnostics; Tesaro
 
Guelhan Inci
Travel, Accommodations, Expenses - Tesaro
 
Klaus Pietzner
Honoraria - Roche Pharma AG
 
Isil Yalcinkaya
No Relationships to Disclose
 
Antje Kristina Belau
No Relationships to Disclose
 
Ekkehard von Abel
No Relationships to Disclose
 
Pauline Wimberger
Travel, Accommodations, Expenses - Roche; Tesaro
 
Jalid Sehouli
Honoraria - AstraZeneca; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca (Inst); Clovis Oncology; Novartis; Roche (Inst); Tesaro (Inst)
Research Funding - Amgen (Inst); Bayer Schering Pharma (Inst); Lilly (Inst); Novartis (Inst)